FMXIN002 in Patients at Risk of Anaphylaxis
FMXIN002 in Patients at Risk of Anaphylaxis
Enrolling by invitation · NCT07045701 · Registry updated 2025-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FMXIN002 in Patients at Risk of Anaphylaxis | Anaphylaxis Food | Enrolling by invitation | Phase 2 / Phase 3 | 2025-07-01 | NCT07045701 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nasus Pharma | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shamir Medical Center | Be’er Ya‘aqov | Israel | 10 |